Concepedia

Lee Schwartzberg

LS

6

Publications

628

Citations

6

H-Index

2004

Active since

Affiliations

Texas Oncology(Current)

Lee Schwartzberg is an author at Texas Oncology specializing in oncology, medicine, and human resource management.

Top concepts

MedicineOncologyHealthAromatasePharmacologyBreast CancerHealth PolicyPublic HealthCancer TherapyClinical Trials

Publications per year

2004–2018

6

Publications

6

Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

Joyce O’Shaughnessy, Lee Schwartzberg, Michael Danso et al. · Journal of Clinical Oncology · 2014 · 299 citations · Full text

Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions

Sonya Blesser Streeter, Lee Schwartzberg, Nadia Husain et al. · Journal of Oncology Practice · 2011 · 242 citations · Full text

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy

Lee Schwartzberg, Eric Roeland, Zoran Andrić et al. · Annals of Oncology · 2018 · 37 citations

Abstract GS4-07: Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor–positive breast cancer

Ian E. Krop, V Abramson, Marco Colleoni et al. · Cancer Research · 2018 · 20 citations

Placebo-controlled Phase 2, Androgen Receptor, Breast Oncology +17

Open‐label, single‐arm, phase <scp>II</scp> study of enzastaurin in patients with follicular lymphoma

Lee Schwartzberg, Róbert Hermann, Ian W. Flinn et al. · British Journal of Haematology · 2014 · 15 citations

Rows per page

1–5 of 6